Acne keloid

L12_ACNEKELOID

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L73.0 Hospital discharge: ICD-9 — 7061D Hospital discharge: ICD-8 — 70611 Cause of death: ICD-10 — L73.0 Cause of death: ICD-9 — 7061D Cause of death: ICD-8 — 70611 2 out of 7 registries used, show all original rules.	66
4. Check minimum number of events None	66
5. Include endpoints None	66
6. Filter based on genotype QC (FinnGen only)	58

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L73
Name in latin: Acne cheloides (scleroticans nuchae)

NAME	L12_ACNEKELOID
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L730
HD_ICD_9	7061D
HD_ICD_8	70611
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L730
COD_ICD_9	7061D
COD_ICD_8	70611
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acne keloid based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	511	157	348
Only index persons	476	151	325
Unadjusted period prevalence (%)
Whole population	0.01	0.00	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	35.43	37.86	34.35
Only index persons	35.04	38.25	33.56

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	58	25	33
Unadjusted period prevalence (%)	0.01	0.01	0.02
Median age at first event (years)	36.38	40.98	32.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
62: Matched controls
620

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L73.0

ICD-10 Finland

Acne keloid

+∞

77.1

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

8.8

13.5

D10BA01

ATC

isotretinoin; oral

15.5

13.1

J01AA07

ATC

tetracycline; systemic

7.4

12.8

L70.0

ICD-10 Finland

Acne vulgaris

65.6

10.0

L73.8

ICD-10 Finland

Other specified follicular disorders

45.1

6.9

D07XC01

ATC

betamethasone; topical

7.3

6.3

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.9

6.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

4.14

5.01

2.5

1.7

—

(36660697) Celiac disease serology panel - Serum

3.48

3.57

1.2

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

136

2.57

3.13

6.8

4.5

3.26

9.30

mg/mmol

1.11

(3012516) Albumin [Mass/volume] in Urine

136

2.57

3.13

5.6

3.7

34.13

50.65

mg/l

0.36

(3033658) Prothrombin time (PT) actual/Normal

138

2.52

3.02

2.9

3.9

101.19

94.94

0.58

138

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

6.50

2.76

5.7

1.0

0.84

1.09

nmol/l

—

(3000330) Specific gravity of Urine by Test strip

4.21

2.56

2.9

4.2

1.02

ratio

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

228

2.23

2.43

2.1

2.0

90.98

95.50

pmol/l

0.30

112

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

4.01

2.22

1.0

—

0.80

—

(42870588) Differential panel, method unspecified - Blood

189

2.14

2.21

7.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2.48

1.94

3.3

3.1

39.69

30.51

u/l

0.51

(40768443) Skin Pathology biopsy report

3.29

1.86

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

3.57

1.79

10.3

5.9

119.17

152.00

mg/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3.15

1.78

2.7

1.5

—

10.46

—

(3028707) Methadone [Presence] in Urine by Screen method

3.53

1.55

3.2

2.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

346

1.94

1.52

7.8

4.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

3.30

1.46

2.6

1.3

22.18

24.62

mmol/l

—

(40768804) Tissue Pathology biopsy report

203

1.81

1.43

2.0

1.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.00

1.42

3.6

2.8

0.49

0.70

e6/l

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.01

1.38

3.6

3.0

0.71

2.16

e6/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.29

1.36

4.2

3.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2.03

1.34

3.1

1.8

15.13

13.85

umol/l

0.19

(3002030) Lymphocytes/Leukocytes in Blood

273

1.76

1.32

8.3

7.8

30.63

28.35

0.67

265

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.93

1.31

1.0

1.2

—

(3006504) Eosinophils/Leukocytes in Blood

266

1.73

1.26

7.9

7.8

2.67

2.74

0.08

257

(3022313) Gas panel - Capillary blood

2.77

1.24

8.2

2.9

—

(3021589) Normoblasts [#/volume] in Blood

238

1.71

1.24

12.4

12.8

0.00

e9/l

0.50

197

(3000494) Fungus identified in Specimen by Culture

2.05

1.23

1.5

—

(3019069) Monocytes/Leukocytes in Blood

267

1.71

1.23

7.9

7.8

8.56

8.82

0.25

259

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.94

1.21

1.2

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.50

1.16

2.6

1.8

—

(3023368) Bacteria identified in Blood by Culture

141

1.74

1.15

4.9

4.8

—

(3026008) Bacteria identified in Urine by Culture

124

1.77

1.14

4.2

3.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2.09

1.13

8.0

6.5

1.26

1.45

mmol/l

—

(3018010) Neutrophils/Leukocytes in Blood

271

1.67

1.13

8.1

7.5

53.87

57.17

1.14

262

(3042936) Bacteria identified in Isolate by Culture

1.90

1.09

2.8

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

235

1.64

1.07

2.5

2.7

—

estimate

—

(3006315) Basophils [#/volume] in Blood

285

1.63

1.04

7.5

7.7

0.04

e9/l

0.18

258

(3028300) Cannabinoids [Presence] in Urine

2.12

1.04

2.9

1.7

—

(3027008) Opiates [Presence] in Urine

2.12

1.04

2.7

1.7

—

(3016879) Cocaine [Presence] in Urine

2.12

1.04

2.6

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.99

0.0

1.3

—

314.46

—

(3027944) Amphetamines [Presence] in Urine

2.00

0.97

2.7

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

2.00

0.97

2.7

1.6

—

(3009343) pH of Capillary blood

2.35

0.96

7.3

2.6

7.40

7.43

—

(3031040) Bacteria [#/volume] in Urine by Automated count

320

1.59

0.93

6.8

4.6

—

45.80

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.85

0.86

5.0

2.7

6.04

5.55

kpa

—

(3018095) Leukocytes [#/volume] in Urine

197

1.55

0.86

6.0

3.9

20.61

9.29

e6/l

0.32

133

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.90

0.81

7.0

4.4

4.52

4.57

pmol/l

—

(3002582) Erythrocytes [#/volume] in Urine

172

1.54

0.80

4.4

3.0

8.69

14.74

e6/l

1.04

128

(3013650) Neutrophils [#/volume] in Blood by Automated count

317

1.51

0.79

14.7

13.5

3.96

3.87

e9/l

0.11

285

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.27

0.78

1.0

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

1.74

0.78

2.9

3.5

1.29

1.84

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

466

1.72

0.77

23.1

18.4

336.44

334.10

g/l

1.12

466

(3002256) Pathology report gross observation

1.71

0.76

1.1

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

2.17

0.76

3.8

2.1

—

(21494755) Public health laboratory ask at order entry panel

0.51

0.74

1.2

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

530

1.93

0.74

22.7

15.4

139.68

139.69

mmol/l

0.01

519

(3019150) Specific gravity of Urine by Refractometry

121

1.56

0.72

3.1

3.9

1.01

1.02

kg/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.92

0.70

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

131

1.53

0.69

2.1

2.9

271.30

983.13

ng/l

—

113

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.79

0.65

1.6

2.4

23.00

24.76

mmol/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.72

0.63

1.4

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1.72

0.63

12.0

7.7

26.00

24.70

mmol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

116

1.51

0.62

1.2

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

286

1.42

0.62

5.8

3.7

0.00

estimate

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.74

0.58

1.2

1.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.74

0.58

1.5

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.53

0.56

8.1

7.9

102.78

104.89

mmol/l

—

(3000492) Spirometry study

1.50

0.55

1.6

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

193

1.40

0.55

6.1

2.9

—

(3044640) Blood type and Crossmatch panel - Blood

176

1.39

0.52

2.0

2.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

124

1.39

0.44

2.1

1.5

2.97

2.64

g/l

0.33

(3022145) Colonoscopy Study observation

1.46

0.44

1.3

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.67

0.44

12.0

8.4

94.80

91.24

—

(3005322) IgE [Units/volume] in Serum or Plasma

1.56

0.42

1.4

3423.00

149.67

u/ml

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.56

0.42

12.0

7.8

0.46

0.68

—

(3015736) pH of Urine

239

1.31

0.42

5.8

3.3

5.93

6.25

0.91

137

(3003396) Base excess in Arterial blood by calculation

1.38

0.42

10.1

7.2

2.56

1.35

mmol/l

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.42

0.0

3.4

—

4.00

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.51

0.41

12.0

7.7

0.90

1.91

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

0.41

0.0

7.1

—

1.67

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.00

0.41

0.0

1.8

—

1.42

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.47

0.40

1.4

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.47

0.40

7.0

3.1

—

(3032080) INR in Blood by Coagulation assay

221

1.30

0.40

5.4

9.0

1.11

1.16

inr

0.33

187

(40761535) Cells panel - Urine sediment

1.42

0.39

9.2

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

155

1.33

0.38

4.0

2.8

0.22

0.19

e6/l

0.05

109

(3000991) Gas panel - Venous blood

1.51

0.37

10.8

6.6

—

(3035350) Ketones [Presence] in Urine by Test strip

284

1.26

0.34

5.9

3.7

0.00

estimate

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

139

1.31

0.34

3.0

3.6

17.19

23.50

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.40

0.32

1.4

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

104

1.32

0.29

2.8

2.2

0.49

0.81

ug/l

—

(40768797) Stomach Pathology biopsy report

0.68

0.28

1.0

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

281

1.21

0.25

6.1

3.6

0.00

estimate

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.38

0.24

2.2

2.6

4.60

4.89

kpa

—

(40758558) Short blood count panel - Blood

165

1.22

0.23

7.8

7.6

—

(4035726) Immunohistochemistry procedure

1.21

0.22

1.2

1.4

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

0.00

0.21

0.0

1.5

—

30.55

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

1.63

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

118

1.24

0.21

1.7

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.21

0.0

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.49

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.21

0.0

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

4.88

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.21

0.0

1.9

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

0.21

0.0

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

415

1.21

0.21

3.6

3.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.31

0.21

1.8

1.6

—

(3018418) pH of Serum or Plasma

147

1.22

0.21

4.5

4.3

7.38

7.40

—

109

(3019832) Treponema pallidum Ab [Presence] in Serum

1.19

0.18

4.0

2.1

—

(3029937) Albumin [Presence] in Urine by Test strip

149

1.19

0.18

4.9

3.5

0.00

estimate

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.15

0.18

1.7

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.22

0.17

2.3

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

199

1.16

0.16

3.5

3.3

11.05

23.39

ng/l

2.84

125

(3013512) EKG study

168

0.86

0.14

4.8

3.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

124

1.17

0.12

3.0

5.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

124

1.17

0.12

2.1

2.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

107

1.15

0.09

2.1

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.13

0.08

2.0

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.84

0.07

3.6

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.87

0.07

3.6

2.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

150

1.09

0.05

2.8

2.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.10

0.03

3.4

2.0

—

(3003694) ABO and Rh group [Type] in Blood

162

1.07

0.02

1.5

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

164

1.05

0.00

5.1

3.1

0.00

estimate

—

(1761868) Lipid panel - Serum or Plasma

249

1.01

0.00

3.6

2.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

216

1.03

0.00

5.0

3.4

0.00

estimate

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.0

—

(44806118) Parainfluenza type 4 nucleic acid detection

0.00

-0.00

0.0

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

35.67

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

105.45

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

3.04

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.6

—

102.20

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.5

—

16.73

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

-0.00

0.0

1.8

—

113.60

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

295.39

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.0

—

(4195642) Thrombophilia screening test

0.00

-0.00

0.0

1.8

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.6

—

32.71

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.4

—

1.20

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.7

—

18.86

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

-0.00

0.0

1.2

—

94.80

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.3

—

202.60

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.4

—

4.01

—

(44790048) Parainfluenza type 2 nucleic acid detection

0.00

-0.00

0.0

1.7

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

2.9

—

88.46

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

26.17

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

-0.00

0.0

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.6

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

2.1

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

2.5

—

11.58

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

-0.00

0.0

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

0.00

-0.00

0.0

1.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.8

—

1.44

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3017732) Neutrophils [#/volume] in Blood

0.87

-0.00

6.0

3.6

2.84

4.70

e9/l

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.3

—

15.74

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.4

—

108.78

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

60.22

—

(44790047) Parainfluenza type 1 nucleic acid detection

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ACNEKELOID and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ACNEKELOID.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ACNEKELOID – Acne keloid

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Acne keloid

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints